Karen Uzark, Eileen King, Linda Cripe, Robert Spicer, Jackie Sage, Kathleen Kinnett, Brenda Wong, Jesse Pratt, James W Varni
Index: Pediatrics 130(6) , e1559-66, (2012)
Full Text: HTML
The purpose of this study was to assess health-related quality of life (QoL) in children with Duchenne muscular dystrophy (DMD), including development and field-testing of a DMD-specific module integrated with the core Pediatric Quality of Life Inventory (PedsQL).The PedsQL 4.0 Generic Core and DMD Module Scales were completed by 203 families, including 200 parents and 117 boys with DMD. Scores on the PedsQL Core Scales were compared with those of matched healthy children. Relationships between PedsQL scores and patient characteristics were examined.By both parent report and child self-report, mean PedsQL scores for boys with DMD were significantly lower than those for healthy children for physical and psychosocial QoL (P < .0001), with significantly impaired psychosocial QoL scores self-reported by 57%. Psychosocial QoL, by self-report only, tended to be higher in the older boys (13-18 years) than in younger boys (8-12 years; P = .05) and was not significantly associated with use of mobility aids. Although parents reported higher Daily Activities scores in boys receiving steroids (P = .01), boys receiving steroids reported no difference in Daily Activities but significantly less worry (P = .004). Parent-child concordance was generally in the fair to poor range. Internal consistency reliability coefficients for PedsQL DMD module scales ranged from 0.66 to 0.86.Overall, boys with DMD reported significantly lower QoL than their healthy peers. Despite decreased physical functioning, older boys seem to perceive better psychosocial QoL than perceived by their parents and by younger boys, unrelated to their need for mobility aids.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Deflazacort
CAS:14484-47-0 |
C25H31NO6 |
Early corticosteroid treatment in 4 Duchenne muscular dystro...
2012-06-01 [Muscle Nerve 45(6) , 796-802, (2012)] |
Treatment of dysferlinopathy with deflazacort: a double-blin...
2013-01-01 [Orphanet J. Rare Dis. 8 , 26, (2013)] |
Acute and chronic corticosteroid treatment of ten patients w...
2012-07-01 [Eur. J. Paediatr. Neurol. 16(4) , 373-8, (2012)] |
Oral pemphigus: long term behaviour and clinical response to...
2000-04-01 [J. Oral. Pathol. Med. 29(4) , 145-52, (2000)] |
Growth hormone treatment in boys with Duchenne muscular dyst...
2012-12-01 [Neuromuscul. Disord. 22(12) , 1046-56, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved